Du Yanru, Huang Wenting, Wang Ying, Lin Jiahe, Xia Niange, Zhu Zhenguo, Wang Xinshi, Xu Yuchen, Xu Huiqin
Department of Neurology, the First Affiliated Hospital of Wenzhou Medical University, Shangcai village, Ouhai District, Wenzhou, Zhejiang Province, P.R. China.
Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, P.R. China.
BMC Pregnancy Childbirth. 2024 Dec 31;24(1):887. doi: 10.1186/s12884-024-07112-8.
We aim to develop a model to predict the probability of tonic-clonic seizures in women with epilepsy (WWE) at any point during pregnancy until six weeks postpartum.
We conducted a screening of patients diagnosed with epilepsy and who were pregnant, at a tertiary hospital in China, during the period of 1 January 2010 to 31 December 2020. We then followed up with these patients for at least one year postpartum. A total of 271 eligible patients were included in the cohort. The outcome was the occurrence of a tonic-clonic seizure during pregnancy or within six weeks postpartum. Predictors were screened through univariate analysis, and models were fitted through multivariate logistic regression analysis. Further, we compared the WMU model with the AntiEpileptic drug Monitoring in PREgnancy (EMPiRE) model in terms of discrimination (the area under receiver operating characteristic curve [AUC]), accuracy (GiViTI calibration belt), decision curve analysis (DCA), net reclassification index (NRI), and integrated discrimination improvement (IDI). Finally, we plotted a nomogram of the WMU model.
Of the 271 pregnant WWE, 62 patients (22.9%) had the outcome. The WMU model included three predictors: age at the time of pregnancy, admission to hospital for seizures in previous pregnancy, and seizures in the 12 months before pregnancy. Compared to the EMPiRE model, the AUC value of the WMU model was higher (0.76 vs. 0.639, P < 0.05). GiViTI calibration belt showed that the predicted risks of the WMU model were mostly consistent with the observed risks. In terms of DCA, the WMU model revealed the highest net proportional benefit for predicted probability thresholds between 10% and 90%. Additionally, our model exhibited better reclassification performance than the EMPiRE model (NRI: 0.331, P < 0.01 and IDI: 0.129, P < 0.01).
We attempted to develop a prognostic model for predicting the risk of tonic-clonic seizures in pregnant WWE. The WMU model showed good performance, but without external validation, it is unclear whether WMU model could be generalized.
我们旨在开发一种模型,以预测癫痫女性(WWE)在孕期直至产后六周内任何时间发生强直阵挛性发作的概率。
我们在中国一家三级医院对2010年1月1日至2020年12月31日期间被诊断为癫痫且怀孕的患者进行了筛查。然后对这些患者进行了至少一年的产后随访。共有271名符合条件的患者被纳入该队列。结局是孕期或产后六周内发生强直阵挛性发作。通过单因素分析筛选预测因素,并通过多因素逻辑回归分析拟合模型。此外,我们在区分度(受试者操作特征曲线下面积[AUC])、准确性(GiViTI校准带)、决策曲线分析(DCA)、净重新分类指数(NRI)和综合区分改善(IDI)方面,将WMU模型与孕期抗癫痫药物监测(EMPiRE)模型进行了比较。最后,我们绘制了WMU模型的列线图。
在271名怀孕的WWE患者中,62名患者(22.9%)出现了该结局。WMU模型包括三个预测因素:怀孕时的年龄、前次怀孕时因癫痫发作入院以及怀孕前12个月内的癫痫发作。与EMPiRE模型相比,WMU模型的AUC值更高(0.76对0.639,P<0.05)。GiViTI校准带显示,WMU模型的预测风险大多与观察到的风险一致。在DCA方面,WMU模型在预测概率阈值为10%至90%之间时显示出最高的净比例效益。此外,我们的模型比EMPiRE模型表现出更好的重新分类性能(NRI:0.331,P<0.01;IDI:0.129,P<0.01)。
我们试图开发一种预测怀孕WWE患者强直阵挛性发作风险的预后模型。WMU模型表现良好,但未经外部验证,尚不清楚WMU模型是否可以推广。